Dr Atul Dwivedi got his PhD from Zhengzhou university (World ranking :590, National ranking 47), China. He served as Assistant Professor, Associate Professor, and Visting Faculty in different universities of China. After completing MBBS degree from Zhengzhou university, he pursued three years Residency in orthopaedic Surgery from The first Affiliated Hospital of Zhengzhou university. He has been invited as a speaker in several international conferences. He sits as editorial board member / Advisory Board member/ reviewer in more than sixty renowned International Indexed Journals. He Authored and coauthored several research papers and book in indexed Journals. His several publication are indexed in semantic scholar, Google scholar, dimension data base and core collection of web of science (Clarivate Analytics), Index Copernicus, CNKI (China National Knowledge Infrastructure) Naver Academic (academic.naver.com), George M. Manuel Library, Carolina University (USA), (Malaysia), Majmaah University,Index Medicus, United States VHL (Virtual Health Library), Brazil. He coauthored and published a book in Germany, which is available on more than 20 online portals worldwide.

Dr. Y. James Kang is the Chief Scientist, Tasly Biopharmaceutical Company, Tianjin; Professor and Director of the Regenerative Medicine Research Center at Sichuan University West China Hospital; Director of Sichuan Regenerative Medicine Research and Technology Center; and Emeritus Professor, University of Louisville, Louisville, KY, USA. Dr. Kang received his Ph.D. in Toxicology and Cell Biology at Iowa State University in 1989 and completed postdoctoral training in Biochemistry and Molecular Biology at Cornell University Medical Center in 1991. He was Assistant Professor of Pharmacology and Toxicology, University of North Dakota School of Medicine (1991-1996); Associate Professor and University Scholar (1996-2001) and Professor and Distinguished University Scholar (2001-2017) in Medicine, Pharmacology and Toxicology, University of Louisville School of Medicine. He served several US-NIH study sections from 1997 to 2006, and other US federal agencies including USDA, US-EPA and US-Veterans Administrations from 1996 to 2005. He was an elected Fellow of the Academy of Toxicological Sciences since 2001, and he was the Editor-in-Chief of Cardiovascular Toxicology (2001-2022). His research interests are in regenerative medicine, focusing on MSCs, tissue injury signaling and organ rejuvenation. He made a major breakthrough in 3D bio-printing of stromal cell-based vascular graft for human implantation, leading the field of MSCs in organ rejuvenation.

Prof. Stefan Bittmann, M.A. is a renowned German board-certified Pediatrician and Professor of Pediatrics at the School of Medicine, Shangluo Vocational and Technical College, University in China. He is also affiliated with the Department of Pediatrics at the Medical and Financial Center Gronau in Germany. Prof. Bittmann is known for his significant contributions to Pediatrics and his role as an international medical consultant. He has actively promoted medical science and cooperation between China and Germany and made notable contributions to global health initiatives and research, especially in the field of Pediatrics.